Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indoor radon gas measurements and its cancer risk using radon-scout detector.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

Micronutrients Levels and Their Association with Osteoporosis and Depression in Elderly Hypertensive Patients: A Case-Control Study.

La Clinica terapeutica·2026
Same author

Evaluating the impact of cenobamate in the management in patients with drug resistant focal epilepsy - A retrospective real world observational study of patients attending NHS Greater Glasgow and Clyde.

Epilepsy research·2025
Same author

General anaesthesia for caesarean delivery in women with class 3 obesity: case series from nine hospitals across the north-west of England (2022-2023).

International journal of obstetric anesthesia·2025
Same author

Utilisation of specialist epilepsy services and antiseizure medication adherence rates in a cohort of people with epilepsy (PWE) accessing emergency care.

Seizure·2024
Same author

The Role of Lipid-Lowering Therapy in Post-Stroke Patients: Update and Recommendations.

Current atherosclerosis reports·2023

Related Experiment Video

Updated: Jul 6, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Acute renal failure: six months pilot study in qatar.

A Rashed1, O Abboud, A Addasi

  • 1Department of Medicine, Hamad General Hospital, Doha, Qatar.

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
|April 15, 2008
PubMed
Summary

Acute renal failure (ARF) affected 0.49% of hospital patients. Renal ischemia was the primary cause, leading to higher mortality compared to nephrotoxic drug-induced ARF.

More Related Videos

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

Related Experiment Videos

Last Updated: Jul 6, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

Area of Science:

  • Nephrology
  • Critical Care Medicine

Background:

  • Acute renal failure (ARF) is a significant complication in hospitalized patients.
  • Identifying the primary causes and outcomes of ARF is crucial for improving patient management.

Purpose of the Study:

  • To investigate the incidence, etiologic factors, and outcomes of acute renal failure in a hospital setting.
  • To compare mortality rates between different causes of ARF and analyze the impact of oliguria.

Main Methods:

  • Retrospective analysis of 11,216 hospital admissions over six months.
  • Diagnosis of ARF based on elevated blood urea nitrogen and creatinine levels.
  • Categorization of ARF causes into renal ischemia and nephrotoxic drugs, with sub-classification of ischemic causes.

Main Results:

  • ARF developed in 0.49% of patients (55/11,216), with a mean age of 51.9 years.
  • Renal ischemia (69%) was the leading cause, followed by nephrotoxic drugs (16.3%). Septic shock and severe hypotension were major contributors to ischemic ARF.
  • ARF patients had a longer hospital stay (15.8 days vs. 5.1 days). Overall mortality was 21.8%, exclusively concentrated in the oliguric group, with significantly higher mortality in ischemic ARF compared to nephrotoxic ARF (p < 0.05).

Conclusions:

  • Renal ischemia, particularly due to septic shock and hypotension, is the predominant cause of ARF in hospitalized patients.
  • Oliguria is a critical indicator of poor prognosis in ARF, irrespective of age.
  • Prompt management of hypotension and judicious use of renal replacement therapies are essential, with a notable difference in survival based on ARF etiology.